Legence to Report 2025 Financial Results on March 27

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Legence Corp. will report 2025 financial results on March 27, 2026, with an earnings call at 10 a.m. EST. A replay will be available through April 27.

Legence to Report 2025 Financial Results on March 27

Legence Corp. (Nasdaq: LGN) has scheduled the release of its fourth quarter and full-year 2025 financial results for March 27, 2026. The company will host a corresponding earnings conference call at 10:00 a.m. EST to discuss the results with investors and analysts.

Investors can access the earnings webcast and accompanying presentation materials through Legence's investor relations website. A replay of the conference call will remain available for one month following the event, through April 27, 2026, allowing those unable to participate in the live broadcast to review the discussion at their convenience.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 20

Related Coverage

GlobeNewswire Inc.

Sika AG Shareholders Approve Board, Boost Dividend to CHF 3.70 Per Share

Sika AG shareholders approved CHF 3.70 dividend and board re-election at 2026 AGM, with company reporting CHF 11.20B sales and 33,700 employees globally.

SXYAY
Benzinga

Nabors Industries Set to Report Q1 2026 Results Amid Energy Market Dynamics

Nabors Industries reports Q1 2026 earnings April 28, followed by management conference call April 29 at 10 a.m. CT with CEO and CFO.

NBR
GlobeNewswire Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.

YQ
The Motley Fool

Slide Insurance Posts $444M Profit on Strong Revenue Growth; Insider Trims Position

Slide Insurance reported $444M net income and $1.16B revenue, up 36% YoY. Director sold $1M in shares via pre-arranged plan while maintaining substantial stake.

SLDE
Benzinga

Alfa Laval Sets Q1 2026 Earnings Release; Conference Call Scheduled for April 22

Alfa Laval will release Q1 2026 earnings April 22, 2026, followed by investor conference call hosted by CEO Tom Erixon and CFO Fredrik Ekström.

ALFVY
GlobeNewswire Inc.

IMUNON Sets March 31 Call to Detail 2025 Results, OVATION 3 Trial Progress

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.

IMNN